Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ketamine for treatment of ADNP syndrome and sensory processing deficits

Ketamine for treatment of ADNP syndrome and sensory processing deficits

US Patent 11571396 · Granted Feb 7, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ketamine and ketamine/nap for treatment of ADNP syndrome and related neurologica2025
Locking adjustment device2025
Firearm optic with locking feature2024
Thermosetting polyimides derived from resveratrol2023
Reducing lost motion in adjustment knobs for riflescopes and other mechanically 2022
Cyanate ester resin2022
Rifle scope with zero lock2022
Diamondoid fuels2021
Thermosetting polyimides derived from resveratrol2021
Low melting and low viscosity thermoset matrix resins from the Z configuration o2021
Diamondoid fuels2021
Fuel production from alcohols2021